Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid? : Multicenter Retrospective Study in France and Switzerland

NCT03636763 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT03636763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03636763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid? : Multicenter Retrospective Study in France and Switzerland
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2018
Completion date
December 31, 2019
Enrollment
183 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid